Researchers have identified a particular cellular protein that affects aging. They’ve also managed to tweak this gene to ...

I voted today, in a presidential election, on Nov. 5, 2024, and I noted the time, too, and I looked hard at the earnest faces ...

Gene therapy has emerged as a transformative technology, offering life-changing treatments for conditions with few options.

Professor Carsten Carlberg has published a comprehensive new textbook, "Gene Regulation and Epigenetics: How Science Works," ...

Gene Munster, Deepwater Asset Management, talks what a Trump presidency means for Tesla. How Did California Vote on Gavin ...

Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

Researchers have identified a specific protein within genetic code that, if tweaked, can extend life by up to 30%, which ...

Paxton Purdy's parents said he has an ultra-rare neurodegenerative genetic mutation. They hope they can raise enough money to ...

Every autumn, thousands flock to Gene's farm for pumpkins, making memories and a new friend. Here's the story of a man ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

The CRISPR tool is capable of repairing the genetic defect responsible for the immune disease chronic granulomatous disease.

Needham analyst Gil Blum maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report) today and set a price target of $6.00.